SUNY Downstate Health Sciences University
Department of Dermatology
Prurigo Nodularis Study:
Eligibility: Must be ≥ 18 years with moderate to severe prurigo nodularis.
Study Procedures: An oral medication (Serlopitant) compared with placebo will be provided. The study will consist of 7 visits and 1 or 2 scheduled phone calls from the study site, for a total study period of 15 to 19 weeks. Blood draws are done at each visit. Compensation is provided.
Pediatric Psoriasis Study:
Eligibility: Must be 6 - 17 years old and have moderate to severe plaque-type PSORIASIS with a body surface area of ≥10%.
Study Procedures: A biologic medication (Taltz®) compared with placebo will be provided. After week 12, all participants receive the biologic medication. Study takes place over 33 months and includes blood draws at each visit. Compensation is provided.
We are recruiting patients for our active clinical trials. If you are interested in participating or obtaining more information, please contact our Dermatology Research Department at 718-270-2991.
Skin Condition Not Listed?
If you have a dermatological condition and would like to be considered for future studies, you are welcome to contact us, and we will add you to our database. We are always looking for patients with Eczema, Psoriasis, Acne, Lupus, skin infection, Hair and Nail conditions, and much more.
For more information, please feel free to reach out to us. We are happy to answer any questions you may have. When emailing, please indicate the study title in the subject line: (ie. "PSORIASIS", "ACNE")
Jeannette Jakus, MD, MBA
Director Of Clinical Trials & Research:
Amy Huang, MD
Pediatric Dermatology Research Fellow